EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Estimating HIV cross-sectional incidence using recency tests from a non-representative sample

Jianan Pan, Marlena Bannick, Fei Gao

American Journal of Epidemiology · 2026-11-04 · 195 (11) · 2847-2853

DOI: 10.1093/aje/kwag075 ↗
AbstractBibliografische Angaben

Abstract

Abstract Cross-sectional incidence estimation based on recency testing is a widely used tool in HIV research. This method has been used to estimate “placebo” incidence in active-control HIV prevention trials by applying the cross-sectional estimator to the screening population data. The application of this approach faces challenges due to nonrepresentative sampling, as individuals aware of their HIV-positive status may be less likely to participate in screening for an HIV prevention trial. To address this, recent phase 3 trials introduced a test-based criterion, excluding individuals who had recently taken an HIV test. To date, the theoretical and empirical validity of this criterion has yet to be studied. We develop a statistical framework incorporating nonrepresentative sampling and the testing-based criterion. We quantify the limiting estimation error in recency-based incidence estimates, and investigate the performance of cross-sectional HIV incidence estimation through simulations emulating real-world trial designs. We find that under nonrepresentative sampling, the incidence estimator is unreliable unless all recently tested individuals are excluded. Additionally, we highlight a bias-variance trade-off: excluding more individuals may reduce estimation bias from nonrepresentative sampling but increases the variability. Our findings emphasize careful application of the testing-based criterion and the importance of improved methods in future HIV prevention trials.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →